Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 3, 2025,…
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:15 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Oct.…
Angelini Ventures Leads 12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company
Through its investment, Angelini Ventures aims to promote the expansion and acceleration…
Appointment of Marc Le Bozec as Interim CEO
Appointment of Marc Le Bozec as Interim CEO Nantes, October 3, 2025,…
FDA approves Roches Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer
Combination reduced the risk of disease progression or death by 46% and…
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
October 02, 2025 10:00 ET | Source: Cirrus Therapeutics, Inc. Cirrus’ lead…
24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Natures Toughest Fiber
DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital…
PharmAla Completes Shipment of LaNeo MDMA to Johns Hopkins
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”…
EssilorLuxottica completes acquisition of Optegra
EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica…
